Latest Insight Market Insights Unlocking the big pharma opportunity in cannabis Before large pharmaceutical players dive deep into cannabis, we believe a few milestones must be achieved.
Portfolio Investments How ZeaKal’s trait technology plans to supercharge hemp growth Behind Canopy Rivers’ Investment of US$10 Million in ZeaKal, Inc.
Portfolio Investments How High Beauty brings cannabis cosmetics to new highs Behind Canopy Rivers' investment in cannabis cosmetics company High Beauty.